You are here
Fullerton Healthcare acquires majority stake in HK medical group
FULLERTON Healthcare Group, a provider of corporate healthcare solutions in Asia, on Wednesday said it has closed the acquisition of a majority stake in Hong Kong medical network HMMP Limited.
The company said the terms of the acquisition are not disclosed, but added that it supports Fullerton Healthcare's mission to transform healthcare standards across Asia, and make healthcare more accessible and affordable throughout the region.
Daniel Chan, deputy CEO of Fullerton Healthcare, said: "The acquisition accelerates our vision to deliver the highest levels of clinical services to our clients across Asia. In acquiring HMMP, we are expanding our Pan-Asian family and improving our reach in the region."
Dr Chan said the acquisition allows Fullerton Healthcare to have immediate access to HMMP's extensive panel and service its wide range of existing clients.
Established in 1996, HMMP manages a network of over 700 medical clinics strategically located across Hong Kong, including general practitioner and specialist clinics, physiotherapy centres, traditional Chinese medicine clinics, and dental clinics, serving multinational companies and government bodies.
HMMP will operate as a stand-alone business unit within Fullerton Healthcare and the existing management will remain and continue to work with its roster of partners.
Said Roco Chiu, managing director of HMMP: "Demand for quality healthcare services and medical expertise referral across Asia is rising, and our strategy has always been to develop a pan-Asian healthcare platform to meet the challenges ahead. By joining forces with Fullerton Healthcare, we look forward to expanding our services to deliver additional value to our patients and partners."